Zhong Nanshan led the recommendation of chloroquine phosphate for the treatment of Wuhan pneumonia into clinical use, although clinical data has long been concluded on the side effects of chloroquine phosphate and hydroxychloroquine sulfate, the domestic and international academic circles have an inhibitory effect on the Wuhan pneumonia virus of hydroxychloroquine sulfate There is also a more consistent attitude.
Source Science and Technology Daily: [Academician Zhong Nanshan leads an expert group that chloroquine phosphate is effective in treating new coronary pneumonia] (http://news.sciencenet.cn/htmlnews/2020/2/435861.shtm)
Chinese introduction to chloroquine phosphate
Chinese researchers submitted a paper “Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro” to the Journal of Nature on February 24, 2020 (Hydroxychloroquine sulfate is lower than chloroquine phosphate Toxic substitutes can effectively inhibit Wuhan pneumonia virus suppression”,
[Original link] (https://www.nature.com/articles/s41421-020-0156-0), the paper was confirmed to be accepted on March 4, and published on March 18.